289 related articles for article (PubMed ID: 6324597)
1. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
Gold PW; Chrousos G; Kellner C; Post R; Roy A; Augerinos P; Schulte H; Oldfield E; Loriaux DL
Am J Psychiatry; 1984 May; 141(5):619-27. PubMed ID: 6324597
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin releasing factor: basic studies and clinical applications.
Chrousos GP; Calabrese JR; Avgerinos P; Kling MA; Rubinow D; Oldfield EH; Schuermeyer T; Kellner CH; Cutler GB; Loriaux DL
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):349-59. PubMed ID: 2999871
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin releasing factor (CRF): diagnostic implications.
Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
[TBL] [Abstract][Full Text] [Related]
5. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
Gold PW; Loriaux DL; Roy A; Kling MA; Calabrese JR; Kellner CH; Nieman LK; Post RM; Pickar D; Gallucci W
N Engl J Med; 1986 May; 314(21):1329-35. PubMed ID: 3010108
[TBL] [Abstract][Full Text] [Related]
6. NIH conference. Clinical applications of corticotropin-releasing factor.
Chrousos GP; Schuermeyer TH; Doppman J; Oldfield EH; Schulte HM; Gold PW; Loriaux DL
Ann Intern Med; 1985 Mar; 102(3):344-58. PubMed ID: 2982307
[TBL] [Abstract][Full Text] [Related]
7. The hypothalamic-pituitary-adrenal axis in depression.
Meltzer HY; Lowy MT; Koenig JI
Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
[No Abstract] [Full Text] [Related]
8. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S
Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
[No Abstract] [Full Text] [Related]
9. The CRFs and their control: chemistry, physiology and clinical implications.
Gillies G; Grossman A
Clin Endocrinol Metab; 1985 Nov; 14(4):821-43. PubMed ID: 3002678
[TBL] [Abstract][Full Text] [Related]
10. Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorder.
Gold PW; Calabrese JR; Kling MA; Avgerinos P; Khan I; Gallucci WT; Tomai TP; Chrousos GP
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):57-65. PubMed ID: 3010382
[TBL] [Abstract][Full Text] [Related]
11. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
Müller OA; Stalla GK; von Werder K
Horm Res; 1987; 25(4):185-98. PubMed ID: 3034758
[TBL] [Abstract][Full Text] [Related]
13. [Corticotropin releasing factor (CRF)-stimulating test in patients with disorders of the hypothalamo-pituitary-adrenal axis].
Hashimoto K; Murakami K; Hattore T; Ota Z
Nihon Naika Gakkai Zasshi; 1984 Sep; 73(9):1317-24. PubMed ID: 6097622
[No Abstract] [Full Text] [Related]
14. Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency.
Gold PW; Chrousos GP
Psychoneuroendocrinology; 1985; 10(4):401-19. PubMed ID: 3878972
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
Zacharieva S; Matrosov P; Stoeva I; Kirilov G
Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
[TBL] [Abstract][Full Text] [Related]
16. Hypercortisolemia and depression.
Gillespie CF; Nemeroff CB
Psychosom Med; 2005; 67 Suppl 1():S26-8. PubMed ID: 15953796
[TBL] [Abstract][Full Text] [Related]
17. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
[No Abstract] [Full Text] [Related]
18. Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder.
Krystal A; Krishnan KR; Raitiere M; Poland R; Ritchie JC; Dunnick NR; Hanada K; Nemeroff CB
J Neuropsychiatry Clin Neurosci; 1990; 2(1):34-43. PubMed ID: 1967010
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
20. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
